EPRX Competitors & Alternatives
Compare Eupraxia Pharmaceuticals Inc. Common Stock with similar stocks in the same industry
Biotechnology
EPRX
Main Stock$8.09
Tradestie Score
36
Market Cap
$307.12M
Analyst Upside
+105.5%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.92
|
$529.35M | 10.0 | 34 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.89
|
$512.39M | - | 41 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$44.09
|
$505.12M | 2.6 | 61 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.85
|
$493.52M | - | 33 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$90.96
|
$492.21M | - | 47 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.86
|
$468.01M | - | 40 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.29
|
$463.20M | - | 43 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.61
|
$457.09M | - | 38 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.85
|
$454.29M | - | 51 | Compare |
More EPRX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry